Lynne Chou O'Keefe - 15 Mar 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
15 Mar 2024
Net transactions value
-$155,883
Form type
4
Filing time
19 Mar 2024, 18:37:29 UTC
Previous filing
20 Dec 2023
Next filing
10 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +10,044 10,044 15 Mar 2024 Direct F1
transaction HIMS Class A Common Stock Sale $155,883 -10,044 -100% $15.52 0 19 Mar 2024 Direct F2
holding HIMS Class A Common Stock 157,874 15 Mar 2024 Held by Define Ventures Fund I, L.P. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -9,134 -25% $0.000000 27,401 15 Mar 2024 Class A Common Stock 9,134 Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -893 -25% $0.000000 2,681 15 Mar 2024 Class A Common Stock 893 Direct F1, F4
transaction HIMS Restricted Stock Unit Options Exercise $0 -17 -24% $0.000000 54 15 Mar 2024 Class A Common Stock 17 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023 by the Reporting Person.
F3 Ms. Chou O'Keefe may be deemed a beneficial owner of the shares held by Define Ventures Fund I, L.P.
F4 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").